Editorial
World J Hepatol
16(1):1-11.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.1
Abstract (566)
|
Core Tip (625)
|
Full Article (HTML) (2226)
|
Figures (1-1) (416)
|
Full Article (PDF)-1204K (179)
|
Full Article with Cover (PDF)-11949K (174)
|
Full Article (XML)-236K (107)
|
Audio-1342K (8)
|
Peer-Review Report-230K (112)
|
Answering Reviewers-97K (98)
|
Received: 10/26/2023
|
Revised: 12/04/2023
|
Accepted: 12/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (2)
|
Total Visits (6609)
|
Similar Articles (77)
|
Timeline of Article Publication (1)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):12-16.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.12
Abstract (621)
|
Core Tip (649)
|
Full Article (HTML) (1576)
|
Tables (1-1) (514)
|
Full Article (PDF)-358K (146)
|
Full Article with Cover (PDF)-11106K (172)
|
Full Article (XML)-54K (97)
|
Audio-1072K (10)
|
Peer-Review Report-236K (91)
|
Answering Reviewers-62K (85)
|
Received: 11/09/2023
|
Revised: 12/05/2023
|
Accepted: 12/19/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5517)
|
Similar Articles (19)
|
Timeline of Article Publication (1)
|
Authors Evaluation (7)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Minireviews
Role of fecal microbiota transplant in management of hepatic encephalopathy: Current trends and future directions

World J Hepatol
16(1):17-32.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.17
Abstract (671)
|
Core Tip (554)
|
Full Article (HTML) (5863)
|
Figures (1-2) (451)
|
Tables (1-5) (453)
|
Full Article (PDF)-1655K (260)
|
Full Article with Cover (PDF)-12399K (202)
|
Full Article (XML)-226K (113)
|
Audio-1259K (9)
|
Peer-Review Report-216K (100)
|
Answering Reviewers-145K (97)
|
Received: 09/16/2023
|
Revised: 12/02/2023
|
Accepted: 01/03/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (14)
|
Total Visits (9988)
|
Similar Articles (63)
|
Timeline of Article Publication (0)
|
Authors Evaluation (2)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
World J Hepatol
16(1):33-40.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.33
Abstract (680)
|
Core Tip (601)
|
Full Article (HTML) (3509)
|
Figures (1-1) (447)
|
Full Article (PDF)-601K (256)
|
Full Article with Cover (PDF)-11346K (133)
|
Full Article (XML)-89K (108)
|
Audio-384K (5)
|
Peer-Review Report-180K (90)
|
Answering Reviewers-74K (100)
|
Received: 10/10/2023
|
Revised: 11/06/2023
|
Accepted: 01/05/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (16)
|
Total Visits (7271)
|
Similar Articles (336)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Retrospective Cohort Study
Direct-acting antivirals failed to reduce the incidence of hepatocellular carcinoma occurrence in hepatitis C virus associated cirrhosis: A real-world study

World J Hepatol
16(1):41-53.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.41
Abstract (654)
|
Core Tip (583)
|
Article Highlights (604)
|
Full Article (HTML) (2259)
|
Figures (1-4) (402)
|
Tables (1-3) (392)
|
Full Article (PDF)-1672K (156)
|
Full Article with Cover (PDF)-12418K (147)
|
Full Article (XML)-173K (94)
|
Audio-467K (6)
|
Peer-Review Report-182K (83)
|
Answering Reviewers-71K (118)
|
Received: 11/21/2023
|
Revised: 12/18/2023
|
Accepted: 01/09/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7345)
|
Similar Articles (2029)
|
Timeline of Article Publication (2)
|
Authors Evaluation (6)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Observational Study
Metabolic puzzle: Exploring liver fibrosis differences in Asian metabolic-associated fatty liver disease subtypes

World J Hepatol
16(1):54-64.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.54
Abstract (619)
|
Core Tip (618)
|
Article Highlights (723)
|
Full Article (HTML) (2022)
|
Figures (1-3) (479)
|
Tables (1-2) (435)
|
Full Article (PDF)-1874K (165)
|
Full Article with Cover (PDF)-12619K (159)
|
Full Article (XML)-114K (110)
|
Audio-386K (15)
|
Peer-Review Report-233K (106)
|
Answering Reviewers-161K (97)
|
Received: 10/02/2023
|
Revised: 10/22/2023
|
Accepted: 12/18/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (8435)
|
Similar Articles (14)
|
Timeline of Article Publication (4)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
Reader Comments (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Basic Study
Subcellular distribution of prohibitin 1 in rat liver during liver regeneration and its cellular implication

World J Hepatol
16(1):65-74.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.65
Abstract (548)
|
Core Tip (526)
|
Article Highlights (608)
|
Full Article (HTML) (1446)
|
Figures (1-4) (387)
|
Full Article (PDF)-5746K (145)
|
Full Article with Cover (PDF)-16492K (131)
|
Full Article (XML)-96K (101)
|
Audio-3997K (7)
|
Peer-Review Report-192K (87)
|
Answering Reviewers-146K (96)
|
Received: 09/30/2023
|
Revised: 11/03/2023
|
Accepted: 11/28/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (5916)
|
Similar Articles (42)
|
Timeline of Article Publication (1)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Rifaximin on epigenetics and autophagy in animal model of hepatocellular carcinoma secondary to metabolic-dysfunction associated steatotic liver disease

World J Hepatol
16(1):75-90.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.75
Abstract (612)
|
Core Tip (579)
|
Article Highlights (630)
|
Full Article (HTML) (2543)
|
Figures (1-4) (394)
|
Tables (1-5) (416)
|
Full Article (PDF)-6006K (187)
|
Full Article with Cover (PDF)-16750K (162)
|
Full Article (XML)-200K (98)
|
Audio-376K (6)
|
Peer-Review Report-182K (105)
|
Answering Reviewers-60K (106)
|
Supplementary Material-355K (104)
|
Received: 11/03/2023
|
Revised: 12/11/2023
|
Accepted: 01/02/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (9248)
|
Similar Articles (1879)
|
Timeline of Article Publication (3)
|
Authors Evaluation (2)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Meta-Analysis
Sorafenib plus transarterial chemoembolization vs sorafenib alone for patients with advanced hepatocellular carcinoma: A systematic review and meta-analysis

World J Hepatol
16(1):91-102.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.91
Abstract (556)
|
Core Tip (622)
|
Article Highlights (617)
|
Full Article (HTML) (1732)
|
Figures (1-4) (410)
|
Tables (1-4) (412)
|
Full Article (PDF)-5941K (150)
|
Full Article with Cover (PDF)-16687K (137)
|
Full Article (XML)-115K (100)
|
Audio-187K (10)
|
Peer-Review Report-215K (96)
|
Answering Reviewers-37K (110)
|
Received: 10/20/2023
|
Revised: 11/21/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (7383)
|
Similar Articles (2503)
|
Timeline of Article Publication (3)
|
Authors Evaluation (5)
|
Article Quality Tracking (1)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Case Report
World J Hepatol
16(1):103-108.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.103
Abstract (592)
|
Core Tip (585)
|
Full Article (HTML) (1408)
|
Figures (1-1) (476)
|
Full Article (PDF)-5068K (163)
|
Full Article with Cover (PDF)-15813K (133)
|
Full Article (XML)-63K (90)
|
Audio-811K (4)
|
Peer-Review Report-266K (106)
|
Answering Reviewers-225K (108)
|
Received: 08/25/2023
|
Revised: 10/24/2023
|
Accepted: 12/12/2023
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (0)
|
Total Visits (6020)
|
Similar Articles (4299)
|
Timeline of Article Publication (0)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open
Letter to the Editor
Review on article of effects of tenofovir alafenamide and entecavir in chronic hepatitis B virus patients

World J Hepatol
16(1):109-111.
Published online Jan 27, 2024.
doi: 10.4254/wjh.v16.i1.109
Abstract (593)
|
Core Tip (592)
|
Full Article (HTML) (1463)
|
Full Article (PDF)-325K (124)
|
Full Article with Cover (PDF)-11079K (127)
|
Full Article (XML)-24K (101)
|
Audio-243K (2)
|
Peer-Review Report-215K (78)
|
Answering Reviewers-19K (81)
|
Received: 10/30/2023
|
Revised: 12/04/2023
|
Accepted: 01/12/2024
|
RCA
|
PubMed Central
|
PubMed
|
CrossRef
|
Google Scholar
|
Times Cited (1)
|
Total Visits (4388)
|
Similar Articles (394)
|
Timeline of Article Publication (5)
|
Authors Evaluation (1)
|
Article Quality Tracking (0)
|
What about the content of this article? (0)
|
Cite
|
(0)
|
Open